The Fool looks at two disruptive healthcare stocks. One is Invitae, which looks to bring genetic testing to the masses. The stock is growing by leaps and bounds and should continue to grow revenue as they gain the business of not just individuals, but insurance companies as well. On analyst thinks that shares can hit $100, but that call seems a little ambitious at this stage in the game.
The second stock is Inspire Medical systems, which has a new way of treating sleep apnea. Many insurance providers (including United Health) are just now approving the device and the company has also begun selling their product in Europe.